Stockreport

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain [Yahoo! Finance]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF Therapeutics (NASDAQ:AXSM) , acquiring 37,433 shares worth $6.84 million in the fourth quarter. What happened According to a Securities and Exchange Commission (SEC) [Read more]